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ABSTRACT
While 18 putative RNA helicases are involved in
ribosome biogenesis in Saccharomyces cerevisiae,
their enzymatic properties have remained largely
biochemically uncharacterized. To better under-
stand their function, we examined the enzymatic
properties of Dpb8, a DExD/H box protein previously
shown to be required for the synthesis of the 18S
rRNA. As expected for an RNA helicase, we demon-
strate that recombinant Dbp8 has ATPase activity
in vitro, and that this activity is dependent on an
intact ATPase domain. Strikingly, we identify Esf2, a
nucleolar putative RNA binding protein, as a binding
partner for Dbp8, and show that it enhances Dbp8
ATPase activity by decreasing the KM for ATP. Thus,
we have uncovered Esf2 as the first example of a
protein co-factor that has a stimulatory effect on a
nucleolar RNA helicase. We show that Esf2 can bind
to pre-rRNAs and speculate that it may function to
bring Dbp8 to the pre-rRNA, thereby both regulating
its enzymatic activity and guiding Dbp8 to its site of
action.
INTRODUCTION
In eukaryotes, members of the family of DExD/H box RNA
helicases are involved in many different steps of RNA meta-
bolism, from RNA processing and RNA export to translation.
The activity of RNA helicases is generally associated with
the separation of RNA strands (‘unwinding’), hence the
name RNA helicase. Recently, it has become evident that
these proteins also have the capacity to anneal RNA strands
or to remodel ribonucleoprotein (RNP) complexes by disrupt-
ing protein–RNA interactions (1–4). Interestingly, the latter
activity does not necessarily involve strand displacement (4).
Thus, the term ‘RNA helicase’ is clearly a very simple
description for the diverse biochemical properties of this
family of proteins.
DExD/H box RNA helicases generally harbor 7–9 con-
served motifs, which comprise the core RNA helicase domain
[reviewed in (5,6)]. These motifs are not only involved in
binding of the RNA substrate, but also are required for bind-
ing and hydrolysis of NTP, generally ATP, and use energy
that is released in this reaction to drive the RNA/RNP remod-
eling steps. The recently discovered Q motif, unique to
DEAD box proteins, has been proposed to function in ATP
and RNA substrate binding (7,8). Motifs I, II and VI are
responsible for binding of ATP and the Mg
2+ co-factor,
whereas motif III (SAT) is implicated in coupling ATP
hydrolysis with RNA unwinding activity.
Because RNA helicases are involved in diverse steps in
gene expression that require large RNA–protein complexes,
it is likely that they are not acting alone but in association
with other proteins. By the accounting of Silverman et al.
in a recent review [Table 1 in (9)], there are at least 36
DExD/H box helicases that may have protein partners.
Close inspection of this list indicates that only a few of the
interactions have been characterized at the molecular level,
and for even fewer have the biochemical parameters of the
helicase been examined. Thus, the function of these putative
co-factors in RNA helicase activity is largely unknown.
Ribosome biogenesis in yeast involves the synthesis of a
35S polycistronic rRNA precursor (pre-rRNA) that is pro-
cessed in large pre-ribosomal particles at several well-deﬁned
sites to produce the mature 18S, 5.8S and 25S rRNAs [for
a recent review see (10)]. This process requires over 200 pro-
teins and hundreds of small nucleolar RNAs (snoRNAs),
which function in cleavage and chemical modiﬁcation of
pre-rRNA via complementary base pairing interactions with
the rRNA. A total of 18 putative RNA helicases are involved
in pre-rRNA processing and ribosome assembly. Mutational
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revealed that conserved amino acids predicted to be involved
in ATP binding and hydrolysis are important for cell
viability, suggesting that they may indeed function as RNA
helicases (11–13). Thus far, only four of the 18 proteins
(Dbp4, Rok1, Dbp9 and Has1) have been characterized
in vitro and have been shown to harbor ATPase activity
(14–17). Two of these proteins (Dbp9 and Has1) were also
able to separate artiﬁcial nucleic acid duplexes in vitro,
suggesting that they are indeed helicases (14,17). However,
biochemical evidence to support this hypothesis for the
other 14 helicases is lacking.
We have begun to study the enzymatic properties of the
RNA helicases involved in ribosome biogenesis in order to
better understand their function. Here we present the bio-
chemical characterization for the yeast DEAD box protein
Dbp8, a putative RNA helicase involved in 18S rRNA syn-
thesis (13). We demonstrate that puriﬁed recombinant Dbp8
exhibits ATPase activity in vitro, and that mutations in the
predicted ATPase domain abrogate Dbp8 ATPase activity.
Strikingly, we identify Esf2, a nucleolar RNA binding protein
required for pre-18S rRNA synthesis (18,19), as a Dbp8-
interacting protein. Using two-hybrid technology and with
puriﬁed recombinant proteins, we show that Esf2 does indeed
directly bind to Dbp8, likely via its C-terminal domain, and
that this interaction substantially increases its ATPase activ-
ity. Thus, optimal ATP hydrolysis activity of Dbp8 depends
on the activity of its protein co-factor, Esf2. Our results sug-
gest a model in which Esf2 recruits Dbp8 to pre-ribosomes by
binding to a region within the pre-rRNA. To our knowledge,
Dbp8 is only the second known eukaryotic RNA helicase that
requires a protein co-factor for optimal function.
MATERIALS AND METHODS
Yeast strains and media
YPH499 (mata, ura3-52, lys2-80, ade2-101, trp1-D63, his3-D
200, leu2-D1) was the parental strain for the construction of
strains used here. Strains carrying genes under the control
of the galactose-inducible promoter or strains carrying triple
HA-tagged genes (Kan
R marker) were generated as described
previously (20). Strains expressing TAP carboxyl-tagged
Dbp8 (Kluyveromyces lactis TRP marker) were generated
as described previously (21). Unless speciﬁcally stated,
strains were grown in YPD (1% yeast extract, 2% peptone
and 2% dextrose) and GAL::3HA strains were grown in
YPG/R (1% yeast extract, 2% peptone, 2% galactose and
2% rafﬁnose) at 30 C. Strains harboring p415GPD::ESF2
plasmids (CEN origin of replication, LEU marker) were
grown at 30 C in SC—leucine (Clontech), supplemented
with 2% dextrose or with 2% galactose and 2% rafﬁnose.
DNA manipulations and in vitro RNA transcriptions
To over-express and purify six histidine-tagged Dbp8 protein,
DBP8 was ampliﬁed by PCR from genomic DNA and cloned
into the pET28a expression vector using BamHI and NotI
restriction sites. To over-express and purify glutathione
S-transferase GST-Esf2, GST-Esf2 DC and GST-Rpa34, the
alleles were ampliﬁed by PCR using genomic DNA as
template and the products were cloned into the pGEX6P-2
vector using BamHI, EcoRI and XhoI restriction sites. All
constructs were veriﬁed by automated DNA sequencing
(W.M. Keck DNA sequencing facility at Yale). For the
yeast 2-hybrid experiments ESF2 was PCR ampliﬁed and
cloned into the pAS2-1 bait vector using NcoI and BamHI
restriction sites. To clone DBP8 into the prey vector
(pACT2), the gene was ampliﬁed by PCR and cloned into
pACT2 using SmaI and BamHI restriction sites. To generate
in vitro transcribed rRNA fragments, rDNA templates
containing a T7 promoter were constructed by PCR using
yeast genomic DNA. The rRNA transcripts were generated
using the MEGAscript kit according to the manufacturer’s
instructions (Ambion).
Expression and purification of recombinant proteins
The fusion proteins were expressed in Escherichia coli BL21
(DE3). Cells were grown in Luria–Bertani (LB) at 37 C sup-
plemented with either kanamycin (pET28a) or ampicillin
(pGEX) to an OD600 of 0.4 and then grown for 1 h at 17 C.
Protein expression was induced with 0.5 mM isopropyl b-D-
thiogalactoside (IPTG) for 16–20 h at 17 C. Cells were
harvested by centrifugation and pellets were resuspended in
5 vol of breaking buffer [150 mM KCl, 50 mM Tris–HCl
(pH 7.4), 10% sucrose, 0.5 mM EDTA, 1 mM b-
mercaptoethanol, 0.01% Igepal (Sigma)] containing a
protease inhibitor cocktail (10 mg/ml aprotinin, 10 mg/ml
leupeptin, 10 mg/ml chymostatin, 10 mg/ml pepstatin,
1.3 mM benzamidine; Sigma) and lysed using a Constant sys-
tems cell disrupter (Low March, Daventry Northants, UK) at
20 000 psi (1350 Bar). Extracts were clariﬁed by ultracentri-
fugation in a Ti45 rotor at 100 000 g for 1 h. To purify recom-
binant six histidine-tagged (His6) Dbp8 proteins, clariﬁed
extracts prepared from  25 g of cells was passed over a
30 ml SP Sepharose column pre-equilibrated with K100 buf-
fer (like K1000 but with 100 mM KCl instead of 1 M). The
SP Sepharose column was subsequently washed with 3 vol of
K100 and bound proteins were eluted with an 80 ml linear
salt gradient (100–1000 mM KCl) prepared in K-buffer
[20 mM KHPO4 (pH 7.4), 0.5 mM EDTA, 10% glycerol,
1m Mb-mercaptoethanol and 0.01% Igepal], followed by a
20 ml K1000 elution. Fractions enriched for His6-Dbp8
were pooled and the mixture was then incubated with 5 ml
of Ni-NTA beads (Qiagen; 1 ml beads / 5 g of cell pellet)
for 1 h at 4 C. The beads were then washed with 10 vol of
K1000 followed by a wash with 10 vol of K300 containing
50 mM imidazole. Proteins were eluted in K300 containing
250 mM imidazole. Fractions containing nearly homogenous
recombinant proteins were pooled and dialyzed for 4 h in
K300 buffer containing 20% glycerol at 4 C.
To purify the GST-Esf2 wild-type and Esf2 DC fusion pro-
teins, clariﬁed extracts prepared from 10 g of cells were
passed over 30 ml Heparin agarose columns (BioRad) and
the fusion proteins were eluted by applying an 80 ml linear
salt gradient (100–2000 mM KCl) prepared in K-buffer, fol-
lowed by 20 ml K2000 elution step. Fractions enriched for
the fusion proteins were pooled ([KCl]  300 mM) and incub-
ated with 4 ml of glutathione–Sepharose beads (Amersham)
overnight at 4 C. After extensively washing the beads with
K300 buffer, the proteins were eluted in K300 containing
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nearly homogenous recombinant proteins were pooled and
extensively dialyzed in K300 buffer containing 20% glycerol
at 4 C. Proteins were frozen in small aliquots in liquid nitro-
gen and stored at  80 C. The purity of the puriﬁed material
was around 90% as judged by SDS–PAGE and Coomassie
blue staining. Protein concentrations were determined using
the Bradford assay as described by the manufacturer
(BioRad).
ATPase experiments
Unless otherwise noted, ATPase assays were carried out
using 10 pmol of recombinant His6-Dbp8 in a Tris-based buf-
fer (pH 7.5) containing 5 mM MgCl2, 1 mM DTT, 1 mg BSA
and 10 mM cold ATP (pH 7.0, Sigma) in a ﬁnal reaction vol-
ume of 10 ml. Radioactive
32P-g-ATP was added as a tracer in
order to quantify the amount of ATP converted to ADP.
Reaction products were separated by thin layer chromato-
graphy and visualized via autoradiography. The ATP conver-
sion rate was determined by quantifying
32P release using a
phosphorimager.
In vitro protein–protein and protein–RNA interactions
For the protein–protein interaction assays, 300 pmol of each
protein was mixed in a K0 buffer [20 mM KHPO4 (pH 7.4),
1 mM DTT and 0.1% Igepal] in a ﬁnal volume of 100 ml.
Unless otherwise noted, the potassium chloride concentration
in the pull-down reactions was 150 mM. After 1 h incubation
on ice, 100 ml of K150 containing 0.1% Igepal was added to
the mixtures and 20 ml was removed for analysis (10% input).
The remainder (180 ml) was subsequently incubated with
20 ml of glutathione–Sepharose beads (Amersham) for 2 h
at 4 C. After this incubation step, 18 ml of the supernatant
was removed for analysis (10% supernatant). The beads
were subsequently washed three times with 500 ml of ice-
cold K150 containing 0.1% Igepal. Bound proteins were
eluted by boiling the beads in SDS–PAGE loading dye and
resolved by 10% SDS–PAGE. Proteins were visualized by
Coomassie brilliant blue staining.
For the protein–RNA interaction assays, 10 pmol of GST-
fusion protein (diluted in K150) was incubated with 10 ng
of in vitro transcribed and
32P-labeled rRNA fragments in
K0 buffer in a ﬁnal volume of 10 ml. KCl was added to a
ﬁnal concentration of 150 mM. After 1 h incubation on ice,
K150 was added to a ﬁnal volume of 200 ml, 20 mlo f
the sample was removed (10% input) and the remainder
(180 ml) was incubated with 20 ml of glutathione–Sepharose
beads (Amersham) for 1 h on ice with regular agitation. The
beads were subsequently washed three times with 500 mlo f
ice-cold K150 containing 0.1% Igepal. Beads were then
resuspended in 300 ml K150 buffer and RNA was isolated
by phenol–chloroform–isoamylalcohol extraction and
ethanol precipitation. Co-precipitated RNAs were resolved
on 6% polyacrylamide-8 M urea gels and visualized by
autoradiography.
Miscellaneous
Yeast 2-hybrid, immunoprecipitation experiments and
western blot analyses were performed as described else-
where (22). Antibodies used: horseradish peroxidase (HRP)
conjugated mouse anti-His6 (Sigma). The 12CA5 anti-HA
monoclonal antibody has been described elsewhere (22).
Motif searches for Esf2 were carried out with Interpro
(http://www.ebi.ac.uk/interpro/), SMART (http://smart.
embl-heidelberg.de/), Prosite (http://us.expasy.org/prosite/)
and the COILS program (http://www.ch.embnet.org/
software/COILS_form.html), (23).
RESULTS
Recombinant Dbp8 has ATPase activity
The presence of the canonical DEAD box motifs in Dbp8
suggests that it may function as an ATPase and possess
RNA unwinding activity. Recent studies have demonstrated
that mutations at conserved amino acids within the putative
ATPase motifs of Dbp8 are lethal, demonstrating that these
motifs are essential for Dbp8 function in vivo (12,13). More-
over, over-expression of these mutants in a wild-type back-
ground causes dominant negative growth defects and delays
in pre-rRNA processing as well as 18S rRNA synthesis
(12,13). These combined results suggested that Dbp8 has
ATP hydrolysis activity and that, furthermore, this activity
is critical for 18S rRNA synthesis. However, biochemical
evidence in support of this hypothesis was lacking. Thus, to
gain more detailed insight into the biochemical properties
of Dbp8 and its role in 18S rRNA synthesis, we have ana-
lyzed the ATPase activity of recombinant Dbp8 proteins
in vitro.
To substantiate the in vivo results, we expressed and
puriﬁed a six histidine-tagged Dbp8 protein (His6-Dbp8)
from E.coli lysates (Figure 1A) and characterized its ATPase
activity under a variety of conditions (Figure 1B–D). Our
results indicated that Dbp8 had a strong preference for
Mg
2+ as metal co-factor (data not shown), was most active
at 30 C (Figure 1B), had a pH optimum for activity of
 7.4 (Figure 1C) and a salt optimum of 300 mM KCl
(Figure 1D). Much to our surprise, under the tested condi-
tions, Dbp8 ATPase activity was not signiﬁcantly stimulated
by the presence of total yeast RNA, single-stranded or
double-stranded DNA (data not shown). The presence of an
excess of RNAse A in the ATPase assay did not noticeably
affect Dbp8 ATP hydrolysis activity and Dbp8 puriﬁed
from RNAse A treated E.coli extracts showed signiﬁcant
ATP hydrolysis activity (data not shown). Thus, under the
tested conditions (pH 7.4, 300 mM KCl, 30 C, 5 mM
MgCl2) Dbp8 ATP hydrolysis activity does not require an
RNA co-factor.
Conserved amino acids within the ATPase motifs are
essential for Dbp8 ATPase activity in vitro
Mutations in the putative ATPase motifs (Motif I and II;
K52A, K52R and D157A) are lethal in vivo and, when
over-expressed, delay pre-rRNA processing and synthesis of
the 18S rRNA (12,13). To correlate these in vivo results with
the biochemical properties of Dbp8, we addressed whether
these mutated proteins were capable of hydrolyzing ATP
in vitro (Figure 2A). Mutant Dbp8 proteins were expressed
and puriﬁed as described above and the quality of the protein
preparations was determined by SDS–PAGE followed by
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an anti-six histidine antibody (Figure 2B). Little or no
degradation products could be detected by either method
and the mutations did not appear to dramatically affect the
accumulation or stability of the protein (Figure 2B). Com-
parison of the ATPase activities of the wild-type and mutant
proteins indicated that wild-type Dbp8 protein hydrolyzed
signiﬁcantly higher amounts of ATP than the Motif I
(K52A and K52R) and Motif II mutants (D157A)
(Figure 2C). Under the tested conditions, the D157A mutant
had  2% of the wild-type activity, whereas the Walker A
mutations reduced ATPase activity roughly 10-fold. Thus,
we conclude that the invariant Motif I lysine and the ﬁrst
aspartic acid in the Motif II are not only essential for cell
viability but also are required for Dbp8 ATP hydrolysis
activity in vitro.
Dbp8 directly interacts with pre-rRNA processing
protein Esf2
Other investigators had previously found that Dbp8 interacts
with Esf2 in a large-scale yeast 2-hybrid screen (18). Esf2
is a nucleolar RRM-containing protein, which, like Dbp8, is
required for processing at sites A0,A 1 and A2 in the pre-
rRNA (19). The 2-hybrid interaction and the similar function
in pre-rRNA processing suggested that they might function
together. We have conﬁrmed the predicted in vivo interaction
through a directed yeast 2-hybrid assay (Figure 3A).
Figure 1. Purified recombinant Dbp8 has ATPase activity. (A) Purification of His6-Dbp8. Extracts prepared from E.coli expressing His6-Dbp8 (lane 3) was
fractionated on a SP Sepharose cation exchange column. The column was extensively washed (lane 5) and proteins were eluted by applying a linear salt gradient.
Fractions containing His6-Dbp8 were pooled (lane 6) and His6-Dbp8 was purified from these fractions to near homogeneity using Ni-NTA beads (lane 7). (B–D)
Optimizing the temperature, pH and salt concentration for Dbp8 ATPase activity. ATP hydrolysis assays were performed at various temperatures (B); 25, 30, 37
and 42 C), different pH (C) and varying potassium chloride concentration (D) with 10 mM ATP. ATP conversion (Y-axis) was calculated after 30 min by
quantifying the phosphate release. Plotted are the averages and standard errors that were derived from three independent experiments.
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recombinant Dbp8 and Esf2 would directly interact in vitro
(Figure 3B). Esf2, expressed and puriﬁed as a GST-fusion
protein from bacterial extracts, was incubated with equimolar
amounts of His6-Dbp8. Reconstituted complexes were
precipitated using glutathione–Sepharose beads and bound
proteins were resolved by SDS–PAGE and stained with
Coomassie brilliant blue. The results show that GST-Esf2
co-precipitated approximately stoichiometric amounts of
Dbp8 (Figure 3B, lane 2). As negative controls we included
GST alone, and two other recombinant proteins: His6-tagged
Fap7 and GST-Rpa34 (Figure 3B, lanes 4–12). Fap7 is
involved in 20S pre-rRNA processing but is not required
for earlier processing steps and is therefore used as a negative
control (24). Dbp8 was shown to co-purify with TAP-tagged
Rpa34 (a subunit of RNA polymerase I) in afﬁnity puriﬁca-
tion experiments (25) and GST-Rpa34 was therefore included
to test a potentially direct interaction with His6-Dbp8.
The results show that Esf2 (predicted pI   8.4) did not
co-precipitate His6-Fap7 (pI   4.4; Figure 3B, lane 5).
Furthermore, GST alone and GST-Rpa34 (pI   9.5) did not
interact with Dbp8 (pI   10) in vitro (Figure 3B, lanes 8
and 11), suggesting that the observed interactions between
Esf2 and Dbp8 are not solely the result of non-speciﬁc elec-
trostatic interactions. We conclude that Dbp8 directly and
speciﬁcally binds Esf2 in vitro.
Finally, to conﬁrm again if these proteins associate in vivo
we performed co-immunoprecipitation experiments using
strains in which Dbp8 was TAP-tagged and Esf2 was tagged
with three copies of the HA tag (3HA). Extracts prepared
from these strains were incubated with IgG Sepharose
beads to immunoprecipitate Dbp8-TAP and co-precipitated
proteins were analyzed by SDS–PAGE and western blot
analysis using anti-HA antibodies (Figure 3C). We found
that a small fraction of HA-tagged Esf2 associated with
TAP-tagged Dbp8 in yeast extracts (Figure 3C, lane 6). As
a positive control we used a strain in which two 66S pre-
ribosome associated proteins were tagged (Rpf2-TAP,
Rpf1-3HA; Figure 3C, lanes 1 and 2). As a negative control
we used a strain in which only Esf2 was 3HA-tagged
(Figure 3C, lanes 3 and 4). Thus, Esf2 directly binds Dbp8
in vitro and is complexed with Dbp8 in vivo.
Figure 2. Dbp8 motif I and II mutants are defective in ATP hydrolysis in vitro.( A) Schematic representation of conserved motifs in Dbp8. The mutations that
were introduced in motifs I and II are indicated by arrows. (B) SDS–PAGE analysis of purified His6-Dbp8 motif I and II mutants. Two mg of each purified
protein was resolved by SDS–PAGE. Proteins were either stained with Coomassie brilliant blue (left panel) or subjected to western blot analysis (right panel)
using anti-His6 antibodies. (C) Motif I and II mutants are ATPase defective. ATP hydrolysis assays were performed with 10 mM ATP, in the presence of 300 mM
KCl and using 10 pmols of Dbp8 wild-type or motif I and II mutant proteins (X-axis). Mixtures were incubated for 30 min at 30 C and ATP conversion (Y-axis)
was calculated after 30 min by quantifying the phosphate release. Plotted are the averages and standard errors that were derived from three independent
experiments
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Esf2 contains a predicted RRM RNA binding domain, and we
therefore examined whether Esf2 would directly bind RNA
(19). Using in vitro transcribed rRNA fragments ( 200–
300 nt in length), we sought to determine if GST-Esf2
binds RNA in vitro. As TAP-tagged Esf2 associates with
the 50ETS of the pre-rRNA in vivo (19), we generated two
radiolabeled rRNA transcripts that largely cover the 50ETS
region (Figure 3D). In addition, we made transcripts that con-
tained 18S and 25S rRNA coding sequences (Figure 3D).
Recombinant GST-Esf2 and GST alone (used as a negative
control) were incubated with the various rRNA transcripts
on ice to allow binding to occur and reconstituted complexes
were precipitated using glutathione–Sepharose beads. Bound
rRNAs were resolved by denaturing PAGE and detected by
autoradiography. The results demonstrate that GST-Esf2 is
able to bind all the tested rRNA fragments although less efﬁ-
ciently to the 50ETS 361–799 rRNA fragment (Figure 3D,
lane 2). Furthermore, GST alone did not interact with any
of the tested rRNA fragments (Figure 3D, lane 5). We con-
clude that recombinant GST-Esf2 binds RNA in vitro, albeit
likely without any apparent sequence speciﬁcity.
Direct binding of Esf2 to Dbp8 stimulates Dbp8 ATPase
activity in vitro likely by increasing its affinity for ATP
Since the two proteins interact, we asked whether Esf2 inter-
action with Dbp8 would stimulate its ATPase activity. We
performed ATPase assays in which increasing amounts of
Esf2 were added to the reactions, up to 1.5 M excess over
His6-Dbp8 (Figure 4A). Because we initially could not detect
a signiﬁcant stimulation of ATPase activity by Esf2 in buffers
containing 300 mM KCl, we performed the reactions with
200 mM KCl and indeed found a modest but signiﬁcant
increase in ATP hydrolysis with increasing Esf2. Under
these conditions, addition of 1.5 M excess of GST-Esf2
to the reaction stimulated Dbp8 ATPase activity  2-fold
(Figure 4A). In contrast, the presence of 1.5 M excess of
GST-Rpa34 did not have a stimulatory effect on Dbp8
ATPase activity. GST-Esf2 and GST-Rpa34 alone showed
only residual background activity, usually consisting of
hydrolyzing 1–5% of the total ATP. For comparison, back-
ground hydrolysis of ATP in buffer during the reaction
times was usually about 1 or 2% (data not shown).
Surprisingly, when we analyzed Dbp8 ATPase activity in
the presence of GST-Esf2 over varying KCl concentrations
(50–450 mM; Figure 4B), the highest Dbp8 ATPase activity
Figure 3. Dbp8 directly interacts with the RNA binding protein Esf2 in vivo
and in vitro.( A) Dbp8 interacts with Esf2 in a yeast 2-hybrid assay. The yeast
2-hybrid host strain carrying the Esf2 bait vector and either Dbp8 prey
vector or empty prey vector were serial diluted and tested for growth on
permissive (+His) or selective media ( His selection). (B) Recombinant
Dbp8 directly binds GST-Esf2 in GST pull-down assays. His6-Dbp8 was
mixed with equimolar amounts of GST, GST-Esf2 or GST-Rpa34 and
incubated on ice for 1 h. As an additional negative control, a GST pull-down
assay was performed with GST-Esf2 and His6-Fap7 (24). GST-fusion
proteins were precipitated using glutathione–Sepharose beads and bound
proteins (‘P’; lanes 2, 5, 8 and 11) were resolved by SDS–PAGE and stained
with Coomassie brilliant blue. Ten percent of the input material (‘I’, lanes 1,
4, 7 and 10) and 10% of the supernatants (‘S’, lanes 3, 6, 9 and 12) was also
analyzed. (C) Esf2 associates with Dbp8 in vivo. Strains expressing various
TAP and/or 3HA-tagged proteins (indicated on top by + or   signs) were
grown in YP media to exponential phase. Extracts prepared from these strains
were incubated with IgG beads for 1 h at 4 C. Immunoprecipitated proteins
were separated by 10% SDS–PAGE and 3HA-tagged proteins were detected
by western blot using mouse monoclonal anti-HA antibodies (12CA5; lanes
2, 5 and 6). As a positive control, immunoprecipitations were performed with
IgG beads using a strain in which two pre-66S associated proteins were
tagged (Rpf1-TAP and Rpf2-3HA; lane 2). As a negative control, a strain was
used in which only Esf2 was 3HA-tagged (lane 5). Five percent of the amount
of extract used for the immunoprecipitation was also analyzed (lanes 1, 3
and 4). The asterisk indicates a yeast protein that is non-specifically
recognized by the anti-HA antibody. (D) GST-Esf2 directly binds RNA
in vitro. GST-Esf2 or GST alone were incubated with various radiolabeled
in vitro transcribed rRNA fragments that contained 50ETS, 18S or 25S
sequences (as illustrated). Complexes were precipitated using glutathione–
Sepharose beads and bound RNAs were resolved by 8% denaturing PAGE
and visualized by autoradiography (lanes 2 and 5). Ten percent of the input
material (‘I’, lanes 1 and 4) and 10% of the supernatants (‘S’, lanes 3 and 6)
were also analyzed.
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KCl concentration. This was not due to lack of Dbp8-Esf2
association under the tested salt concentrations, as the
in vitro binding of GST-Esf2 to His6-Dbp8 was not dramat-
ically affected as judged by pull-down experiment with
nickel-NTA beads (Figure 4B). These results suggest that
Esf2 is a stimulatory factor for Dbp8 ATPase activity.
To determine the mechanism of how binding of Esf2 to
Dbp8 could stimulate its ATPase activity, we determined
Michaelis–Menten kinetic parameters in the presence or
absence of Esf2. ATP hydrolysis was measured at varying
ATP concentrations (10–500 mM) and in the presence or
absence of equimolar amounts of Esf2. Initial velocities (v)
were calculated after 3 min of incubation at 30 C. During
this time period we observed a linear correlation between
time and the amount of ATP hydrolyzed (data not shown).
Average velocities were ﬁtted to the Michaelis–Menten
equation and KM (ATP) and kcat values were calculated
(Figure 4C). When bound to Esf2, Dbp8 has a KM for ATP
of 86 mM,  2-fold lower than the KM of Dbp8 alone
(194 mM). Under the tested conditions, Dbp8 binding to
Esf2 increased the kcat from 17 min
 1 to 52 min
 1. Thus,
Esf2 stimulates Dbp8 ATP hydrolysis activity likely by
increasing its afﬁnity for ATP, thereby increasing its ATPase
activity.
The C-terminal domain of Esf2 is required for binding
to Dbp8 and for stimulating Dbp8 ATPase activity
If Esf2 is indeed a co-factor for Dbp8 enzymatic activity,
Esf2 binding to Dbp8 should be required for function.
Bioinformatics searches for conserved protein motifs in
Esf2 indicated that it had two coiled-coil domains (40–67
and 225–254 amino acids) on either side of the RRM (98–
196 amino acids). Since coiled-coil domains can function
as protein–protein interaction scaffolds [reviewed in (26)],
we predicted that one of these domains might be involved
in Dbp8 binding. To test this, we generated a number of
Esf2 deletion mutants (Figure 5A) and assayed their ability
to interact with Dbp8 in a directed yeast 2-hybrid assay
(Figure 5B). Deletion of the ﬁrst 90 amino acids, including
the ﬁrst coiled-coil domain, (Esf2 DN) or deletion of the pre-
dicted RRM motif (Figure 6A; 91–205 amino acids; Esf2
DRRM) did not noticeably impair interaction with Dbp8. In
contrast, the C-terminal deletion mutant (Figure 5A; Esf2
DC) failed to interact with Dbp8 in the 2-hybrid assay
(Figure 5B), suggesting that amino acids 206–317, which
include one of the coiled-coil domains, are required for bind-
ing to Dbp8. When tested in the ATP hydrolysis assay, the
Esf2 DC mutant, which did not bind Dbp8, also no longer
substantially stimulated Dbp8 activity (9-fold for Esf2 WT
versus 2-fold for Esf2 DC; Figure 5C). Therefore, Esf2
Figure 4. (A) Esf2 stimulates Dbp8 ATP hydrolysis activity in vitro. A total
of 10 pmol of Dbp8 was incubated with various amounts of GST-Esf2 or
GST-Rpa34 (0–1.5 M excess over Dbp8, X-axis) in buffers containing
200 mM KCl, for 25 min on ice to allow complex formation to occur. ATP
was then added to the reaction and ATP hydrolysis (Y-axis) was measured
after 30 min of incubation at 30 C. Plotted are the averages and standard
errors that were derived from three independent experiments. (B) Esf2-
mediated stimulation of Dbp8 ATPase activity is optimal at lower potassium
chloride concentrations. ATP hydrolysis assays were performed using 5 pmol
of recombinant Dbp8 and GST-Esf2 and varying salt concentrations (50–
450 mM KCl). ATP hydrolysis was measured after 30 min of incubation at
30 C. Plotted are the averages and standard errors that were derived
from three independent experiments. To determine if under these conditions
GST-Esf2 and Dbp8 still form a complex, 300 pmols of each protein were
incubated under the same conditions used for the ATP hydrolysis assay.
Protein complexes were precipitated using Ni-NTA beads, resolved by SDS–
PAGE and stained with Coomassie brilliant blue [Figure embedded in the
graph shown in (B)]. (C) Dbp8 binding to Esf2 increases Dbp8 affinity
for ATP and increases the ATP turnover rate. ATP hydrolysis assays were
performed using 5 pmols of Dbp8 in the presence or absence of equimolar
amounts of Esf2 in 50 mM KCl and various ATP concentrations. The initial
velocities, plotted on the Y-axis, were determined by measuring the amount of
ATP hydrolysis (mM) during a 3 min period (data not shown) in the presence
of various [ATP] (10, 50, 100, 250 and 500 mM). The data were fitted to the
Michaelis–Menten equation from which the KM and kcat were determined.
Plotted are the averages derived from two independent experiments.
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C-terminal domain of Esf2 is required for Dbp8 binding.
Finally, we determined whether the mutant Esf2 proteins
were functional in vivo. Since Esf2 is essential for viability,
we tested whether the deletion mutants could support growth
using a strain where the endogenous protein was under the
control of a galactose-inducible/dextrose repressible promoter
(GAL::3HA-ESF2). Serial dilutions of cells expressing the
wild-type or mutant Esf2 proteins or carrying empty vector
(p415GPD) were spotted on galactose based solid medium
(to verify even spotting of the culture) and plates containing
dextrose media (to deplete endogenous Esf2). The results
show that the Esf2 DC and DRRM mutants were unable
to support growth in cells depleted of endogenous Esf2
(Figure 5D). Interestingly, the N-terminal deletion did not
appear to dramatically affect Esf2 function, since this mutant
alleviated the growth defect in Esf2-depleted cells as well as
the wild-type protein expressed from the plasmid.
Collectively, these results suggest that the C-terminal
domain of Esf2 is essential for function, required for binding
to Dbp8 and for stimulation of ATPase activity. In contrast,
the N-terminal region ﬂanking the putative RRM motif is
neither required for Esf2 function nor binding to Dbp8.
50ETS rRNA fragments stimulate Dbp8 ATPase
activity in vitro
The association of Esf2 with the 50ETS RNA in vitro and
in vivo [this work, (19)], prompted us to investigate whether
pre-rRNAs stimulate Dbp8 ATPase activity. We tested total
yeast RNA (type III; Sigma) and the four rRNA transcripts
that bound to GST-Esf2 in the in vitro binding studies
(Figure 3D). We found only a small increase in Dbp8 ATPase
activity ( 1.35-fold; Figure 6A) at 50 mM KCl with equimo-
lar amounts GST-Esf2 and Dbp8 (1 mM) in the presence of
the 50ETS rRNAs (0.8 mM; 1–360, 361–799; Figure 6A). In
contrast, total yeast RNA (1 mg/ml), the 18S rRNA and the
25S rRNA transcripts did not have any signiﬁcant stimulatory
effect under the tested conditions. To corroborate these
results we performed titration experiments to determine the
concentration of 50ETS 0-360 RNA required for optimal
Dbp8 ATPase activity and to test whether stimulation was
dependent on the Esf2 co-factor (Figure 6B). Surprisingly,
the best degree of stimulation by rRNA (6-fold under these
conditions) occurred in the absence of Esf2 when equimolar
Figure 5. The essential C-terminal domain of Esf2 is required for binding
to Dbp8 and stimulating its ATPase activity in vitro.( A) Schematic
representation of the Esf2 wild-type (WT) and deletion mutants (DN, DC and
DRRM) that were tested in the yeast two-hybrid screen for their association
with Dbp8. The predicted RRM motif and coiled-coil domains are
represented as boxes. The amino acid positions relevant to the deletions
made are indicated. (B) The C-terminal domain of Esf2 is required for Dbp8
interaction in the yeast 2-hybrid assay. The yeast 2-hybrid host strain carrying
either the Esf2 wild-type or Esf2 deletion mutants (bait) in combination with
either Dbp8 (prey) or empty prey vector were serial diluted and tested for
growth on permissive (+His) or selective media (His selection). (C) The
C-terminal domain of Esf2 is required for stimulation of Dbp8 ATPase
activity in vitro. ATP hydrolysis experiments were performed with 10 mM
ATP, 5 pmol of Dbp8 and 50 mM KCl, in the presence or absence (Dbp8
alone) of 5 pmols of GST-Esf2 wild-type (WT) or GST-Esf2 DC. ATP
hydrolysis (plotted on the Y-axis) was measured after 30 min incubation at
30 C. Graphed are the averages and standard errors derived from three
independent experiments. (D) The C-terminal domain of Esf2 is essential for
function in vivo. Serial dilutions (10-fold) of GAL::3HA-ESF2 strains
carrying the empty vector or, p415GPD-ESF2 wild-type and mutant alleles
(DN, DRRM and DC) were grown in synthetic galactose media (SG/R-LEU)
and spotted on either galactose containing plates (left panel; SG/R-LEU) or
galactose containing plates (right panel; SD-LEU).
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the reaction (Figure 6B). However, while rRNA was stimulat-
ory for ATPase activity, the effect is small compared to the
stimulatory effect of the Esf2 co-factor (30-fold under these
conditions).
DISCUSSION
We have characterized the in vitro enzymatic activity of
Dbp8, a DEAD box helicase required for small ribosomal
subunit biogenesis (13). We identify the RRM-containing
protein, Esf2, also required for small ribosomal subunit bio-
genesis (19), as a Dbp8 binding protein that acts as an auxili-
ary factor to stimulate Dbp8 ATPase activity. The C-terminal
domain of Esf2 is required for Dbp8 binding, for stimulation
of ATP hydrolysis and for its in vivo function. We show that
Esf2 also binds promiscuously to RNA, and that while some
rRNA fragments stimulate Dbp8 ATPase activity, Esf2 is
a more potent stimulator of ATPase activity than RNA.
We have thus shown that Esf2 is a co-factor for Dbp8 ATP
hydrolysis.
Our ﬁndings indicate that Dbp8 is typical of a DExD/H box
RNA helicase with respect to its ATP hydrolysis activity
[using Table 1 in Cordin et al. (6) as a basis for comparison].
It differs from most other DExD/H box RNA helicases char-
acterized in vitro in that, under the conditions that we have
used, its ATPase activity does not require added RNA.
There is, however, a slight stimulation of ATPase activity
when in vitro transcribed rRNA is added. Notably, of the
ﬁve other DEAD box helicases required for ribosome biogen-
esis that have been studied in vitro, three do not require RNA
for ATPase activity (Dbp4, Dbp9 and Rok1), one requires
it (Has1), and Rrp3 was not studied in enough detail
(14–17,27). In contrast, the bacterial DExD/H box protein
DbpA, also involved in ribosome biogenesis, has an absolute
requirement for a speciﬁc portion of the 23S rRNA for
in vitro ATP hydrolysis (28,29).
Since DExD/H box RNA helicases generally participate in
cellular processes that require RNA–protein complexes, it is
not surprising that many DExD/H box helicases have known
interacting proteins (9) and in some cases a single helicase
can have multiple interacting proteins. New partners for cel-
lular helicases continue to be identiﬁed, including ones from
human viral pathogens, such as cytomegalovirus (CMV) (30).
In general, protein co-factors are thought to increase the
ATPase and unwinding activities of their associated helicase.
They can also have other effects. For example, the interaction
of the NS4A protein of hepatitis C virus with the viral DExD/
H helicase NS3 changes the helicase substrate speciﬁcity
from DNA to RNA (31). In addition, an RNA helicase can
act as an RNA chaperone, as in the case where the helicase
CYT19 recruits CYT18 (tyrosyl-tRNA synthetase) to splice
the group I intron in yeast mitochondria (32).
However, of the studied interactions, there are only a
handful of examples where the mechanism of the effect of
the protein co-factor on helicase enzymatic properties has
been elucidated in vitro. The eukaryotic translation factor
DExD/H box RNA helicase eIF4A has several co-factors,
of which eIF4B and eIF4G are the most well-studied. Both
stimulate ATPase activity and RNA unwinding (33–37). As
with the effect of Esf2 on Dbp8, addition of the eIF4B co-
factor to the helicase eIF4A increases its afﬁnity for ATP
(38). Similarly, RhlB, involved in RNA degradation as part
of the E.coli degradosome, interacts with RNase E, which
stimulates its ATPase activity (39).
What is the mechanistic role of Esf2 in enhancing the
ATPase activity of Dbp8? Esf2 binding to Dbp8 may stabilize
the tertiary structure of Dbp8 or induce a conformational
change that is optimal for Dbp8 activity. A similar mechan-
ism has been proposed for the translation initiation factors
eIF4A and its co-factor eIF4G, two proteins that are part of
the eIF4F complex involved in recruiting the small ribosomal
Figure 6. Pre-rRNA fragments stimulate Dbp8 ATPase activity in vitro.
(A) In vitro transcribed fragments of the 50ETS rRNA stimulate Dbp8 ATP
hydrolysis in the presence of Esf2. ATP hydrolysis assays were carried out
with 10 mM ATP, 10 pmol of Dbp8 and 10 pmol of Esf2, 1 mg/ml of total
yeast RNA, 0.8 mM of ribosomal RNAs (schematically outlined on top of
the graph) and 50 mM KCl. Samples were incubated at 30 C for 30 min.
Plotted are the averages and standard errors derived from three independent
experiments. (B) In vitro transcribed 50ETS rRNA fragments stimulate Dbp8
ATP hydrolysis in the absence of Esf2. ATP hydrolysis experiments were
performed with 10 mM ATP, 5 pmol of Dbp8 and 50 mM KCl, in the presence
or absence of equimolar amounts of Esf2 and various amounts of 50ETS
rRNA (0–360 fragment; plotted on the X-axis). ATP hydrolysis (plotted on
the Y-axis) was measured after 30 min incubation at 30 C. Plotted are the
averages and standard errors derived from three independent experiments.
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Based on solution structure studies, it has been proposed
that binding of eIF4G to the C-terminal domain of eIF4A
enhances the enzymatic activities by stabilizing an orientation
of the two globular helicase domains that supports the
‘active’ conformation of eIF4A, a model that has been
referred to as the ‘soft clamp’ model (34). Thus, it is tempting
to speculate that Esf2 regulates Dbp8 activity by inducing a
conformation that switches Dbp8 into its active state.
Although we have demonstrated ATPase activity for Dbp8,
we have not been able to show ATP hydrolysis-dependent
strand separation (also sometimes referred to as ‘RNA
unwinding’). Using RNA substrates with 12 bp duplexes,
we could frequently detect strand separation of substrates
containing 30 overhangs, but not blunt or substrates with
50 overhangs (S. Granneman, C. Y. Lin and S. J. Baserga,
unpublished data). Unfortunately, this activity was also regu-
larly observed in the absence of ATP and with an ATPase
defective Dbp8 mutant protein, suggesting that binding of
Dbp8 to the substrate with the 30 overhang was sufﬁcient to
separate the strands. Thus, we have been unable to unequi-
vocally demonstrate energy dependent RNA unwinding or
strand separation by Dbp8, and have therefore not been
able to adequately test the role of Esf2 in this process.
Previous experiments have shown that Dbp8 and Esf2 are
protein components of the large RNP, the SSU processome
[also called 90S pre-ribosome; (19,40)], and as such are
complexed with 40+ proteins and one or more snoRNAs.
Consistent with SSU processome function, Esf2 has been
found to be associated with 50ETS rRNA fragments by
immunoprecipitation (19). One intriguing possibility is that
Esf2, as an RNA binding protein, acts to facilitate the inter-
action of Dbp8 with its RNA or RNP target. Thus, binding of
Dbp8 to Esf2, possibly through its C-terminal coiled-coil
domain, may not only activate Dbp8, but could also serve
to place it near its site of action. Of note is that other studied
DExD/H box helicase co-factors that stimulate ATPase
activity (eIF4B, eIF4G and RNase E) are also RNA binding
proteins, indicating that this is likely to be a general theme
among helicase co-factors.
Several possible functions have been ascribed to the RNA
helicases involved in ribosome biogenesis. Because many
have been found associated with large pre-ribosomal com-
plexes, it has been suggested that they facilitate the numerous
RNP remodeling steps, including disrupting rRNA–rRNA or
protein–rRNA interactions, necessary for the maturation of
ribosomal subunits. They could also facilitate rRNA–rRNA
interaction, as helicases have been found to have an annealing
activity (3). Another hypothesized function is that they
unwind snoRNAs from the pre-rRNA after the chemical
modiﬁcation or cleavage steps have occurred. Consistent
with this model, the DExD/H box RNA helicase Dbp4 has
recently been shown to be required for the release of the
U14 snoRNA from the pre-rRNA, although it remains unclear
whether it is Dbp4 that unwinds the duplex (15). In all cases,
the natural RNA or RNP substrates of the helicases involved
in ribosome biogenesis have unfortunately remained elusive
(11,12,15,41,42). It is probable that, like Dbp8, the seventeen
other DExD/H box helicases required for ribosome bio-
genesis carry out their function in rRNA unwinding, RNP
remodeling or rRNA annealing in conjunction with a speciﬁc
co-factor that stimulates their activity and perhaps directs
them to their target substrate.
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